Back to search

Article

Mapping the Regional Distribution of Molecular Tumor Board Patients and Identifying White Spots in our Catchment Area – a Joint Approach of the CCC WERA Alliance

2022-05-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Molecular Tumor Boards (MTBs) are crucial instruments for discussing and allocating targeted therapies to suitable cancer patients based on genetic findings. Currently, limited evidence is available regarding the regional impact and the outreach component of MTBs. <h4>Methods</h4> We analyzed MTB patient data from four neighboring Bavarian tertiary care oncology centers in Wür...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef73cfa1-5b48-56cf-adda-b20ce8806202
DOI
10.1101/2022.05.15.22275106
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mapping the Regional Distribution of Molecular Tumor Board Patients and Identifying White Spots in our Catchment Area – a Joint Approach of the CCC WERA AllianceDOI 10.1101/2022.05.15.22275106
The WERA Cancer Center Matrix: Strategic Management of Patient Access to Precision Oncology in a Large and Mostly Rural Area of GermanySemantic proximity
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity
Unlocking precision oncology by establishing a nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer: the BALLETT studySemantic proximity
Implementation of a Clinical Decision Support System for Precision Oncology across an Academic NetworkSemantic proximity
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.Semantic proximity
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.Semantic proximity
From biobank and data silos into a data commons: convergence to support translational medicineSemantic proximity
Genomic expertise in action: molecular tumour boards and decision‐making in precision oncologySemantic proximity
Select a neighboring publication to make it the new centre.